Product Specifications:

Item# 7005 :  Recombinant Human APOBEC3G (CEM15, E.coli)

 

Concentration: See vial                                                              

 

Mass/vial: 100ug                                                               

 

Diluent: PBS, 30% Glycerol 0.1% Sarcosyl                                                                       

 

Purity: >95%                                                                       

 

Stabilizer: None                                                                        

 

Preservative: None

 

Storage: -75°C

 

Physical State: Frozen Liquid

 

Stability: 6 Months at -85°C               

 

Aplications: Vif Binding Assays. 

 

Description: Produced in the E.coli Expression System as a hexa-His fusion protein. Thrombin cleavage site at N-terminus may be used to derive CEM15 free of hexa-His sequence.

 

Approximate mol.wt: 44kD.

 

Purification: This protein is purified by preparative SDS-PAGE, reduced, to >95% purity as determined by SDS-PAGE, reduced.

 

Specificity: This protein binds to anti-CEM15 murine monoclonal antibodies  and rabbit polyclonal antibodies as determined by Elisa and Western Elisa.      

 

Biological Activity:  Binds HIV-1 vif as determined by ELISA and Western Blot, and complexes with native vif in HIV infected cells.

 

Application and Instructions for use

Research articles related to Recombinant Human APOBEC3G

APOBEC3G is a cytidine deaminase with two homologous domains and restricts retroelements and HIV-1. APOBEC3G deaminates single-stranded DNAs via its C-terminal domain, whereas the N-terminal domain is considered non-catalytic. Although APOBEC3G is known to bind RNAs, APOBEC3G-mediated RNA editing has not been observed. We recently discovered RNA editing by the single-domain enzyme APOBEC3A in innate immune cells. To determine if APOBEC3G is capable of RNA editing, we transiently expressed APOBEC3G in the HEK293T cell line and performed transcriptome-wide RNA sequencing. We show that APOBEC3G causes site-specific C-to-U editing of mRNAs from over 600 genes. The edited cytidines are often flanked by inverted repeats, but are largely distinct from those deaminated by APOBEC3A. We verified protein-recoding RNA editing of selected genes including several that are known to be involved in HIV-1 infectivity. APOBEC3G co-purifies with highly edited mRNA substrates. We find that conserved catalytic residues in both cytidine deaminase domains are required for RNA editing. Our findings demonstrate the novel RNA editing function of APOBEC3G and suggest a role for the N-terminal domain in RNA editing. Recombinant human APOBEC3G contains highly-edited mRNAs

 

immunodx重组抗原重组抗原是从实验室而不是从其生物学来源人工制造的抗原。就像天然抗原一样，它们能够使免疫系统发挥作用，从而使人体免受伤害。 并非市场上所有的重组抗原都是相同的。来自我们的  ImmunoDX具有极高的质量，并且与天然同类产品高度相似。 为了生产理想用于各种研究和诊断目的的重组抗原，我们使用了一些最具创新性和可靠性的蛋白质工程方法。由于一切都在我们的工厂中进行，因此我们保证了重组抗原纯度，特异性和生物活性的高水平标准。 我们的重组抗原以相同的方式非常接近天然抗原。但是，它们的生产不受诸如高需求和高税率等约束因素的影响。ImmunoDX可以以少量成本提供大量一流的重组抗原。 ImmunoDX的重组抗原非常适合  各种各样的应用，包括用于产生商业用途抗体的免疫程序。 多年来，ImmunoDX一直专门从事与关节炎，癌症，结核病，艾滋病等相关的研究和诊断的特殊生物学产品的生产。我们还提供许多其他相关的产品和服务。